Adma Biologics | ADMA - Current Assets


Adma Biologics reported $402.66M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Adma Biologics USD 402.66M 3.1M Sep/2025
Alnylam Pharmaceuticals USD 4.05B 97.85M Dec/2025
BioCryst Pharmaceuticals USD 404.35M 48.66M Dec/2025
Minerva Neurosciences USD 83.1M 70.08M Dec/2025
Novavax USD 978.28M 3.69M Dec/2025
Omeros USD 69.65M 26.53M Jun/2025
Takeda JPY 3.12T 195.82B Dec/2025